SK3 Group Inc. (SKTO) With the two most recent PR's it

New Post Public Reply Private Reply Replies (2) Message Board

Mar 12, 2014 at 8:10 AM

SK3 Group Inc. (SKTO)

With the two most recent PR's it appears we are starting to focusing more on the legitimacy of the company, its' products and accomplishments..................GO SKTO

Pre-market news no less............................I like it.

LOS ANGELES, CA--(Marketwired - Mar 12, 2014) - SK3 Group, Inc. (OTC Pink: SKTO) (PINKSHEETS: SKTO), doing business as Medical Greens, through its subsidiary Berkely Bio-Organic Research Laboratories, has completed beta-testing of the initial offering in its recently announced phyto-cannabinoid product line, T-Hydrocan™. T-Hydrocan™ RMC 40 contains 40 mg. of refined mixed cannabinoids which have been extracted from cannabis flowers utilizing solvents approved for food contact, refined via numerous filtration and separation processes to remove as many of the non-cannabinoid elements as possible, and pressed into a chewable tablet.

Unlike Medical Greens' non-psychoactive Dharmanol™ product line, T-Hydrocan™ RMC 40 contains fully-activated (decarboxylated) THC, producing the classic effects of medical marijuana via an orally-consumed tablet.

"While we are most excited about the possibilities of the non-psychoactive cannabinoids, the great bulk of the research, as well as the majority of the scientific knowledge of the medicinal healing effects ascribed to cannabis medicine, come from research performed on psychoactive THC. Orally-consumed doses of various types and strengths of traditional cannabis extracts have shown substantial efficacy in treating pain, anxiety, insomnia, anorexia, as well as numerous other conditions. T-Hydrocan RMC 40 tablets have been designed to benefit those seeking relief from these, and many other conditions that have been successfully treated with medicinal cannabis," said David Hoye of Berkeley Bio-Organic Research Laboratory.

Each tablet of T-Hydrocan™RMC 40 contains the following ingredients specifically:

1. Microcrystalline cellulose;
2. Magnesium stearate (vegetable source);
3. Sucrose;
4. Dextrin;
5. Natural flavorings;
6. Vitamin C as ascorbic acid (a preservative); and
7. Purified oil of cannabis / hemp containing 40 mg. of refined mixed phyto-cannabinoids.

T-Hydrocan™ RMC 40 tablets will now be packaged and made available to qualified California medical patients through the network of medicinal collectives serviced and managed by Medical Greens, as well as through the Pharmajanes.com ordering platform.

Several other products in the T-Hydrocan™ product line are being prepared for beta-testing and will soon follow the release of T-Hydrocan™ RMC 40. On the other end of the spectrum from the RMC (refined mixed cannabinoids) offering, T-Hydrocan™ Whole Plant, will contain as many of the over 400 natural medicinal elements of the cannabis/hemp plant as possible, removing only the fiber. Many patients have found the "whole plant" approach preferable to eliminating any possible medicinal element that is present in the natural plant when it is processed into an orally ingested medicine.

Following T-Hydrocan™ Whole-Plant will be T-Hydrocan™ Citrolene™ tablets, which will combine the effects of active cannabinoids with those of the natural terpene d-Limonene. This natural medicine, d-Limonene, is found in cannabis/hemp as well as in many other plants. It has relaxing, anti-anxiety, and anti-spasmodic effects, as it binds with the same receptors in the human body as does the benzodiazapines Valium and Xanax, but has been shown to be non-toxic and non-addictive.

"We are pleased to have completed this step in the development process and are looking forward to seeing T-Hydrocan™ RMC-40 tablets available through our managed collectives and Pharmajanes.com within the next 60 days," said Artemus Mayor, President of Medical Greens. "This development demonstrates our commitment to medical cannabis focused products to deliver more of what our patients want when they want it."

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy doing business as Medical Greens™ and focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Investor Relations
SK3 Group, Inc. d.b.a Medical Greens
investors@medicalgreens.com

GO BANK

GO MGMJ

"PEACE"

"I'd buy that for a Dollar"

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epic Political Thriller Explores Humanity's Future

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...

Cala Launches Game-Changer Wearable for Tremor Relief

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Purina Institute Highlights Nutritional Science at WSAVA 2026

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

NYSE Texas Redefines the U.S. Capital Markets Landscape

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

ROKFORM’s Signal Card: A Wallet Tracker for All

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Karoo Health Leaps Forward with New CCO Breton

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...

Charter Next Generation Unveils Gen 2 MDO-PE Films

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Pushing for National Liver Cancer Awareness in 2026

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

Navigating Holiday Sweets: Healthy Balancing Acts

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...